These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 27911315
1. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes. Jurjević I, Miyajima M, Ogino I, Akiba C, Nakajima M, Kondo A, Kikkawa M, Kanai M, Hattori N, Arai H. J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315 [Abstract] [Full Text] [Related]
2. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease. Jingami N, Asada-Utsugi M, Uemura K, Noto R, Takahashi M, Ozaki A, Kihara T, Kageyama T, Takahashi R, Shimohama S, Kinoshita A. J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256 [Abstract] [Full Text] [Related]
3. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test. Kang K, Ko PW, Jin M, Suk K, Lee HW. J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892 [Abstract] [Full Text] [Related]
4. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Rauramaa T, Nagga K, Leinonen V, Tullberg M. J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811 [Abstract] [Full Text] [Related]
10. Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus. Akiba C, Nakajima M, Miyajima M, Ogino I, Motoi Y, Kawamura K, Adachi S, Kondo A, Sugano H, Tokuda T, Irie K, Arai H. J Alzheimers Dis; 2018 Oct; 63(3):989-1002. PubMed ID: 29710721 [Abstract] [Full Text] [Related]
11. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study. Abu-Rumeileh S, Giannini G, Polischi B, Albini-Riccioli L, Milletti D, Oppi F, Stanzani-Maserati M, Capellari S, Mantovani P, Palandri G, Cortelli P, Cevoli S, Parchi P. J Alzheimers Dis; 2019 Oct; 68(2):723-733. PubMed ID: 30883350 [Abstract] [Full Text] [Related]
12. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Kazui H, Kanemoto H, Yoshiyama K, Kishima H, Suzuki Y, Sato S, Suehiro T, Azuma S, Yoshimine T, Tanaka T. J Neurol Sci; 2016 Oct 15; 369():236-241. PubMed ID: 27653897 [Abstract] [Full Text] [Related]
18. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus. Vanninen A, Lukkarinen H, Kokkola T, Koivisto AM, Kokki M, Musialowicz T, Hiltunen M, Zetterberg H, Leinonen V, Herukka SK, Rauramaa T. J Alzheimers Dis; 2023 Oct 15; 94(2):727-736. PubMed ID: 37334597 [Abstract] [Full Text] [Related]
19. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus. Azuma S, Kazui H, Kanemoto H, Suzuki Y, Sato S, Suehiro T, Matsumoto T, Yoshiyama K, Kishima H, Shimosegawa E, Tanaka T, Ikeda M. Psychogeriatrics; 2019 Nov 15; 19(6):527-538. PubMed ID: 30916850 [Abstract] [Full Text] [Related]
20. Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade. Moriya M, Miyajima M, Nakajima M, Ogino I, Arai H. PLoS One; 2015 Nov 15; 10(3):e0119973. PubMed ID: 25821958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]